Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2020 Earnings Conference Call November 13, 2020 8:30 AM ET Company Participants Will O’Connor – Stern Investor Relations Peter Nielsen – President and Chief Executive Officer Anthony Price – Senior Vice President-Finance, Accounting and Administration Conference Call Participants Boobalan Pachaiyappan – H.C. Wainwright Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings’ Third Quarter 2020 Earnings Conference Call. At this time, all particip ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----------- ...

Bio-Path Holdings Inc (NASDAQ:BPTH) Q2 2020 Results Conference Call August 14, 2020 8:30 AM ET Company Participants Will O’Connor - Stern Investor Relations Peter Nielsen - President, Chief Executive Officer and Chief Financial Officer Anthony Price - Senior Vice President of Finance, Accounting and Administration Conference Call Participants Laura Ingalls - Stone Gate Capital Partners Yi Chen - H.C. Wainwright Operator Ladies and gentlemen, good morning, and welcome to the Bio-Path Holdings Second Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | | ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2020 Results Earnings Conference Call May 15, 2020 8:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern Investor Relations Peter Nielsen - President, Chief Executive Officer and Chief Financial Officer Anthony Price - Senior Vice President of Finance, Accounting and Administration Conference Call Participants Yi Chen - H.C. Wainwright & Co. Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings First Quarter 2020 Earnings C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 87-0652870 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital Market FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or ¨ TRANSITIO ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2019 Earnings Conference Call March 6, 2020 8:30 AM ET Company Participants Will O'Connor - Stern IR Peter Nielsen - President & CEO Anthony Price - VP, Finance & Accounting Conference Call Participants Yi Chen - H.C. Wainwright Laura Engle - Stonegate Capital Partners Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Year End 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. Following the formal remark ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number 001-36333 BIO-PATH HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0652870 (State or other jurisd ...

Bio-Path Holdings, Inc (NASDAQ:BPTH) Q3 2019 Earnings Conference Call November 15, 2019 8:30 AM ET Company Participants Kerry Conlin - Stern Investor Relations Peter Nielsen - President and Chief Executive Officer Anthony Price - Vice President, Finance and Accounting Conference Call Participants Laura Engle - Stonegate Capital Partners Yi Chen - H.C. Wainwright Operator Good morning ladies and gentlemen. Welcome to the Bio-Path Holdings Third Quarter 2019 Earnings Conference Call. At this time, all partici ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | |----------------- ...